THE APOLIPOPROTEIN B (APO B) TEST MEASURES THE AMOUNT OF A SPECIFIC PROTEIN INVOLVED IN CARRYING CHOLESTEROL IN THE BLOODSTREAM. HIGH LEVELS OF APO B ARE LINKED TO AN INCREASED RISK OF HEART DISEASE AS ITS PRIMARILY FOUND IN BAD CHOLESTEROL (LDL). THIS TEST CAN PROVIDE A MORE ACCURATE ASSESSMENT OF HEART DISEASE RISK COMPARED TO TRADITIONAL CHOLESTEROL MEASUREMENTS, ESPECIALLY IN INDIVIDUALS WITH HIGH TRIGLYCERIDES.

THE APOLIPOPROTEIN A-I (APO A-I) TEST MEASURES THE AMOUNT OF A SPECIFIC PROTEIN INVOLVED IN CARRYING GOOD CHOLESTEROL (HDL) IN YOUR BLOOD. APO A-I IS CRUCIAL FOR REMOVING EXCESS CHOLESTEROL FROM CELLS AND TRANSPORTING IT TO THE LIVER FOR DISPOSAL. WHILE HDL LEVELS ARE OFTEN USED TO ASSESS HEART DISEASE RISK, THE APO A-I TEST PROVIDES MORE DIRECT INFORMATION ABOUT THE FUNCTION OF HDL PARTICLES. THIS TEST CAN BE HELPFUL IN EVALUATING CARDIOVASCULAR RISK, ESPECIALLY IN INDIVIDUALS WITH LOW HDL LEVELS OR A FAMILY HISTORY OF HEART DISEASE.

TESTOSTERONE FREE IS A TERM USED TO DESCRIBE A CONDITION WHERE AN INDIVIDUAL HAS VERY LOW OR NO TESTOSTERONE LEVELS IN THEIR BODY. THIS CAN OCCUR NATURALLY DUE TO AGING, CERTAIN MEDICAL CONDITIONS, OR AS A RESULT OF TREATMENTS FOR CONDITIONS LIKE PROSTATE CANCER. SYMPTOMS OF LOW TESTOSTERONE CAN INCLUDE FATIGUE, REDUCED LIBIDO, DECREASED MUSCLE MASS, AND MOOD CHANGES. IF YOU SUSPECT YOU MAY HAVE LOW TESTOSTERONE LEVELS, ITS IMPORTANT TO CONSULT WITH A HEALTHCARE PROFESSIONAL FOR PROPER DIAGNOSIS AND TREATMENT.

A total testosterone test measures the combined levels of both free and bound testosterone in the blood. This is the most common type of testosterone test and is typically used to assess overall testosterone levels. Its important to note that while total testosterone provides valuable information, it does not directly reflect the biologically active form of the hormone.

PSA (PROSTATE-SPECIFIC ANTIGEN) TOTAL IS A BLOOD TEST USED TO SCREEN FOR PROSTATE CANCER. PSA IS A PROTEIN PRODUCED BY THE PROSTATE GLAND, AND ELEVATED LEVELS CAN INDICATE PROSTATE CANCER OR OTHER PROSTATE PROBLEMS LIKE BENIGN PROSTATIC HYPERPLASIA (BPH). HOWEVER, ITS IMPORTANT TO NOTE THAT PSA LEVELS CAN ALSO BE RAISED BY FACTORS OTHER THAN CANCER, SUCH AS PROSTATE INFLAMMATION OR AN ENLARGED PROSTATE. THEREFORE, PSA TESTING SHOULD BE USED IN CONJUNCTION WITH OTHER DIAGNOSTIC TESTS TO EVALUATE PROSTATE HEALTH.

A Lipid Profile is a blood test that measures the levels of different types of fats (lipids) in your blood.It includes total cholesterol, LDL (bad) cholesterol, HDL (good) cholesterol, and triglycerides.This test helps assess your risk of heart disease and stroke.By understanding your lipid profile, you can work with your healthcare provider to manage cholesterol levels through diet, exercise, and medication if necessary.

Kidney Function Tests (KFTs) evaluate how well your kidneys are filtering waste products from your blood. These tests typically include measurements of creatinine, blood urea nitrogen (BUN), and electrolytes. By assessing these values, healthcare providers can identify potential kidney problems, monitor kidney disease progression, and evaluate the effectiveness of treatment. KFTs are crucial for individuals with diabetes, high blood pressure, or a family history of kidney disease.

A COMPLETE BLOOD COUNT (CBC) IS A COMPREHENSIVE BLOOD TEST THAT PROVIDES INFORMATION ABOUT THE CELLS IN YOUR BLOOD. IT MEASURES THE NUMBER OF RED BLOOD CELLS, WHITE BLOOD CELLS, AND PLATELETS, AS WELL AS HEMOGLOBIN (THE PROTEIN THAT CARRIES OXYGEN) AND HEMATOCRIT (THE PERCENTAGE OF RED BLOOD CELLS IN YOUR BLOOD). A CBC IS USED TO DIAGNOSE AND MONITOR A WIDE RANGE OF CONDITIONS, INCLUDING ANEMIA, INFECTIONS, BLEEDING DISORDERS, AND BLOOD CANCERS.

THE EGFR IS A CALCULATION THAT ESTIMATES HOW WELL THE KIDNEYS ARE FILTERING WASTE FROM THE BLOOD. IT IS AN IMPORTANT INDICATOR OF KIDNEY FUNCTION. A LOW EGFR SUGGESTS A DECLINE IN KIDNEY FUNCTION AND IS USED TO DIAGNOSE AND STAGE CHRONIC KIDNEY DISEASE (CKD).

THIS ASSAY IS USEFUL FOR EVALUATING HYPOGONADISM AND OLIGOMENORRHEA IN FEMALES. IT ASSESSES OVARIAN STATUS INCLUDING FOLLICLE DEVELOPMENT FOR IN VITRO FERTILIZATION. IT EVALUATES FEMINIZATION INCLUDING GYNECOMASTIA IN MALES. THIS ASSAY FORMS A PART OF THE DIAGNOSIS AND WORK UP OF PRECOCIOUS AND DELAYED PUBERTY IN FEMALES. IT IS ALSO USEFUL IN MONITORING LOW DOSE FEMALE HORMONE REPLACEMENT THERAPY IN POST MENOPAUSAL WOMEN AND FOR MONITORING ANTI-ESTROGEN THERAPY.